Björn Löwenadler
Corporate Officer/Principal chez TOLERANZIA AB
Profil
Björn Löwenadler is currently the Director at Adjuvare AB and the Chief Business Officer at Toleranzia AB.
He previously held positions as an Independent Director at Alzinova AB, Director at Agrisera AB, Head of Discovery Sciences at AstraZeneca PLC, Head of Molecular Biology at Pharmacia Corp., Chief Scientific Officer at Arexis AB, and Head of Discovery Research at BioVitrum.
Dr. Löwenadler obtained a doctorate degree from Karolinska Institutet.
Postes actifs de Björn Löwenadler
| Sociétés | Poste | Début |
|---|---|---|
| TOLERANZIA AB | Corporate Officer/Principal | - |
Adjuvare AB
 Adjuvare AB Miscellaneous Commercial ServicesCommercial Services Adjuvare AB is a Swedish company that offers biotechnology research and development services. | Directeur/Membre du Conseil | - |
Anciens postes connus de Björn Löwenadler
| Sociétés | Poste | Fin |
|---|---|---|
Agrisera AB
 Agrisera AB Miscellaneous Commercial ServicesCommercial Services Part of Summa Equity AB, Agrisera AB is a Swedish company that produces primary and secondary antibodies for plant and algal cell biology research. The company is based in Vannas, Sweden and provides antibodies for plant and algal research, with prompt delivery worldwide, and reactivity to thousands of species. Agrisera ships worldwide and offers professional technical support. The company was founded in 1985. Erika Gelfgren has been the CEO of the company since 2012. | Directeur/Membre du Conseil | - |
| BioVitrum | Corporate Officer/Principal | - |
| ALZINOVA AB | Directeur/Membre du Conseil | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | - |
Formation de Björn Löwenadler
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ALZINOVA AB | Health Technology |
| TOLERANZIA AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| BioVitrum | |
Agrisera AB
Agrisera AB Miscellaneous Commercial ServicesCommercial Services Part of Summa Equity AB, Agrisera AB is a Swedish company that produces primary and secondary antibodies for plant and algal cell biology research. The company is based in Vannas, Sweden and provides antibodies for plant and algal research, with prompt delivery worldwide, and reactivity to thousands of species. Agrisera ships worldwide and offers professional technical support. The company was founded in 1985. Erika Gelfgren has been the CEO of the company since 2012. | Commercial Services |
Adjuvare AB
Adjuvare AB Miscellaneous Commercial ServicesCommercial Services Adjuvare AB is a Swedish company that offers biotechnology research and development services. | Commercial Services |
